Log In
BCIQ
Print this Print this
 

GWP42004

  Manage Alerts
Collapse Summary General Information
Company GW Pharmaceuticals plc
DescriptionOral cannabinoid
Molecular Target Cannabinoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today